Price
70.21
+0.14%52W Range
Market Cap
₹863.01 Cr
Traded: ₹2.38 Cr (0.28%) 0.0x
Free Float: ₹202.03 Cr (1.18% of FF traded)
Volume · 60D trend
3.37 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | -- | -- | +13.0% | -- | -- | -- |
| Sales | -- | +13.0% | -- | -- | +18.0% | Accelerating |
| Profit | -- | +12.0% | -- | -- | +58.0% | Accelerating |
| Return | -- | -- | -- | -- | -- | -- |
Quarterly Results
Dec 2025
Jun 2025
Mar 2025
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025 | Jun 2025 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | 104 | 115 | 100 | 73 | 107 |
| Expenses | 93 | 100 | 84 | 63 | 94 |
| Operating Profit | 12 | 15 | 15 | 10 | 13 |
| OPM % | 11.3% | 13.1% | 15.3% | 13.8% | 11.9% |
| Other Income | 2 | 4 | 2 | 1 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 2 | 3 | 2 | 2 | 2 |
| Profit Before Tax | 11 | 15 | 14 | 8 | 10 |
| Tax % | 23.9% | 29.4% | 25.2% | 23.7% | 22.6% |
| Net Profit | 8 | 11 | 10 | 6 | 8 |
| Exceptional Items | 0 | 0 | -0 | 0 | -1 |
| EPS (Rs) | 0.7 | 1.0 | 0.9 | 0.6 | 0.7 |
| Sales Growth (YoY) | 43.2% | 8.0% | -- | -- | -- |
| Sales Growth (QoQ) | -9.3% | 15.6% | 36.6% | -31.6% | -- |
| OP Growth (YoY) | 16.8% | 19.1% | -- | -- | -- |
| OP Growth (QoQ) | -22.0% | -1.4% | -- | -20.6% | -- |
| Profit Growth (YoY) | -- | 30.7% | -- | -- | -- |
| EPS Growth (YoY) | 13.8% | 41.4% | -- | -- | -- |
| EPS Growth (QoQ) | -33.3% | 5.3% | 62.1% | -17.1% | -- |
| OP Margin | 11.3% | 13.1% | 15.3% | 13.8% | 11.9% |
| Net Margin | 7.7% | 9.5% | 10.5% | 8.9% | 7.3% |
| Material Cost % | 56.0% | 56.0% | 52.0% | 53.0% | 60.0% |
| Employee Cost % | 13.0% | 13.0% | 12.0% | 15.0% | 11.0% |
| P/S | 2.20 | -- | -- | -- | -- |
| P/E | 22.15 | -- | -- | -- | -- |
| P/B | 3.70 | 3.48 | -- | -- | -- |
Exchange Filings
42Pursuant to the Provisions of Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 and Regulation 7(2), of the SEBI (Prohibition of Insider Trading) ....
Pursuant to the Provisions of Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 and Regulation 7(2) of the SEBI (Prohibition of Insider Trading) ....
Pursuant to the Provisions of Regulations 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations 2011 and Regulation 7(2) of the SEBI (Prohibition of Insider Trading) ....
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr Nikhil Kelkar
Pursuant to the provisions of Regulation 30 of Listing Regulations, please find enclosed transcript of the Earnings Conference Call held on August 14, 2026, for un-audited Standalone and ....
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vikram Kelkar
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Anuradha Arun Kelkar
Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Pursuant to the Provisions of Regulation 30 of the Listing Regulations, it is hereby informed that Audio recording of earnings Conference call was held today i.e August 14th, 2026 for Unaudited ....
Disclosure under regulation 30 of SEBI regulations, 2015 - Investor Presentation
Newspaper publication of the unaudited financial results of the company for the quarter ended 30th June 2026
Pursuant to the provisions of Regulation 30 of the Listing Regulations, please find enclosed herewith the earnings release for the Financial Results for the Quarter ended June 30, 2026
The alteration of the Articles of Association of the Company, Subject to the Members approval.
1. Recommend Re-appointment of Mr. Arun Purushottam Kelkar (DIN: 00171276) as Chairman & Director of the Company, Subject to the approval of the Members of the Company. The Requisite disclosures ....
Convening of the 33rd Annual General Meeting of the Members of the Company on Tuesday, September 22, 2026, at 11:30 AM through Video Conferencing/other Audio Visual Means as may be applicable. ....
Recommend a Final Dividend of Rs. 0.30 Paise per Equity Share of Face Value of Rs. 1/- for the Financial Year ended March 31, 2026, and fixed Tuesday September 15, 2026, as the Record Date ....
1. Approved the unaudited Standalone and Consolidated Financial Result of the Company for the quarter ended June 30th, 2026, and took on record the limited review report issued by the Statutory ....
1. Approved the unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026, and took on record the Limited Review Report issued by the Statutory ....
Q1 FY 27 Conference Call - To discuss the operational and Financial Performance
Q1 FY27 Conference Call - To discuss the operational and financial performance for the quarter ended 30th June 2026
Hexagon Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited financial results ....
Transcript of the earnings conference call held on 17th July 2026 for audited standalone & consolidated financial results for the quarter and year ended March 31, 2026
Disclosure under regulation 30 of SEBI Regulations, 2015 - Q4FY26 result presentation
Clarification with respect to disclosure contained in the Red Herring Prospectus/Prospectus pursuant to regulation 30 of SEBI (LODR) Regulations, 2015
Pursuant to the provisions of Regulation 30 of the Listing Regulations, it is hereby informed that audio recording of Earnings Conference Call held today i.e. July 17, 2026 for Audited ....
Pursuant to the provisions of Regulation 30 of the Listing Regulations read with Para A (15)(a) of Part A of Schedule III thereto, this is to inform you that a conference call for analysts/institutional ....
Pursuant to the provisions of Regulation 30 of the Listing Regulations read with Para A (15)(a) of Part A of Schedule III thereto, this is to inform you that a conference call for analysts/institutional ....
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended June 30, 2026.
Hexagon Nutrition Limited has informed the Exchange regarding Resignation of Mr. Subhash Purushottam Kelkar from the Position of Executive Director with effect from 06th July 2026
Hexagon Nutrition Limited has informed the Exchange regarding Resignation of Mr. Subhash Purushottam Kelkar from the Position of Executive Director with effect from 06th July 2026
Hexagon Nutrition Limited has informed the Exchange regarding Resignation of Mr. Aditya Kelkar from the Position of Non-Executive Director with effect from 06th July 2026
Hexagon Nutrition Limited has informed the Exchange regarding Resignation of Mr. Aditya Kelkar from the Position of Non-Executive Director with effect from 06th July 2026.
Hexagon Nutrition Limited has informed the Exchange regarding Resignation of Mr. Subhash Purushottam Kelkar from the Position of Executive Director with effect from 06th July 2026
Hexagon Nutrition Limited has informed the Exchange regarding Resignation of Mr. Aditya Kelkar from the Position of Non-Executive Director with effect from 06th July 2026.
Submission of Copy Newspaper Advertisement dated July 02, 2026
Outcome of Board Meeting Dated 30th June, 2026.
Re-appointment of Internal auditor for FY 2026-27.
We are submitting Financial Results (Standalone & consolidated) for 31/03/2026
Re-appointment of cost auditor for FY 2026-27.
We would like to inform that Dr. Nikhil Arun Kelkar, a Promoter and Joint Managing Director of our Company, holds citizenship of New Zealand. It is further noted that Dr. Nikhil Arun Kelkar ....
Hexagon Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2026 ,inter alia, to consider and approve To consider and approve the ....
Hexagon Nutrition Limited has informed the Exchange regarding the Trading Window Closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015